Canopy Growth (CGC) Inventory Average (2017 - 2026)
Canopy Growth (CGC) posted Inventory Average of $78.1 million for Q1 2026, up 4.13% sequentially from $75.0 million in Q4 2025, and up 18.28% YoY from $66.1 million in Q1 2025.
Canopy Growth (CGC) Inventory Average (2017 - 2026) Analysis & Trends
Canopy Growth has reported Inventory Average for 10 years, with the latest figure at $78.1 million in Q1 2026.
- Quarterly Inventory Average rose 18.28% year-over-year to $78.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $78.1 million (up 18.28% YoY) and the FY2026 annual result came in at $78.1 million, up 25.5% from the prior year.
- Inventory Average improved to $78.1 million in Q1 2026 per CGC's latest filing, from $75.0 million in the prior quarter.
- Over five years, Inventory Average peaked at $225.8 million in Q1 2022 and troughed at $59.6 million in Q2 2024.
- A 5-year average of $97.6 million and a median of $75.0 million in 2025 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2023 and 2026: Inventory Average tumbled 59.67% in 2023, then gained 18.28% in 2026.
- Over 5 years, Inventory Average stood at $160.0 million in 2022, then tumbled by 59.67% to $64.5 million in 2023, then grew by 1.49% to $65.5 million in 2024, then increased by 14.56% to $75.0 million in 2025, then climbed by 4.13% to $78.1 million in 2026.
- According to Business Quant data, Inventory Average over the past three periods registered $78.1 million, $75.0 million, and $71.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 1.41 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.20 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.56 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 8.99 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 186.05 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 84.35 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.74 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 824.00 Mn |
| 10 | Canopy Growth | 445.49 Mn | 198.48 Mn | 16.08 Mn | 79.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 79.13 Mn |
| Mar 31, 2026 | 78.14 Mn |
| Dec 31, 2025 | 75.04 Mn |
| Sep 30, 2025 | 71.05 Mn |
| Jun 30, 2025 | 67.44 Mn |
| Mar 31, 2025 | 66.06 Mn |
| Dec 31, 2024 | 65.50 Mn |
| Sep 30, 2024 | 63.92 Mn |
| Jun 30, 2024 | 59.58 Mn |
| Mar 31, 2024 | 60.60 Mn |
| Dec 31, 2023 | 64.55 Mn |
| Sep 30, 2023 | 85.50 Mn |
| Jun 30, 2023 | 83.66 Mn |
| Mar 31, 2023 | 109.63 Mn |
| Dec 31, 2022 | 160.02 Mn |
| Sep 30, 2022 | 161.78 Mn |
| Jun 30, 2022 | 161.34 Mn |
| Mar 31, 2022 | 225.82 Mn |
| Dec 31, 2021 | 285.42 Mn |
| Sep 30, 2021 | 307.79 Mn |